Prostate News Archive
03-Mar-2009
Study Of Prostate Cancer Risk Factors Funded At UIC By $3 Million Award (Medical News Today)
Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy have been awarded a five-year, $3 million grant from the National Cancer Institute to study the link between body fat and prostate cancer progression. Desert Regional Medical Center in Palm Springs offers free prostate screenings (The Desert Sun)
Desert Regional Medical Center is offering free prostate screenings for men age 45 and older. Aberrant Activation Of Androgen Receptor In A New Neuropeptide-Autocrine Model Of Androgen-Insensitive Prostate Cancer (Medical News Today)
UroToday.com - In the January 2009 issue of Cancer Research, Dr. Joy Yang and colleagues reported a new animal model of neuropeptide mediated prostate cancer (CaP). Neuropeptides are released by CaP cells at the time of androgen deprivation. They are one of 5 mechanisms that can facilitate castration-resistant CaP growth. Cell Genesys Announces Final Results From Phase 3 Program Of GVAX Immunotherapy For Prostate Cancer (Medical News Today)
Cell Genesys, Inc. (NASDAQ:CEGE) announced today results from further analyses of VITAL-1, the Company's recently terminated Phase 3 clinical trial which compared GVAX immunotherapy for prostate cancer to TaxotereŽ (docetaxel) chemotherapy plus prednisone and enrolled 626 advanced prostate cancer patients with asymptomatic castrate-resistant metastatic disease.
Back to Prostate News Archive
